首页> 美国卫生研究院文献>other >Inflammation and the Host Response to Injury a Large-Scale Collaborative Project: Patient-Oriented Research Core—Standard Operating Procedures for Clinical Care VII—Guidelines for Antibiotic Administration in Severely Injured Patients
【2h】

Inflammation and the Host Response to Injury a Large-Scale Collaborative Project: Patient-Oriented Research Core—Standard Operating Procedures for Clinical Care VII—Guidelines for Antibiotic Administration in Severely Injured Patients

机译:大型合作项目:炎症和宿主对伤害的反应:以患者为中心的研究核心-临床护理的标准操作程序VII-重伤患者的抗生素给药指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

When the clinical decision to treat a critically ill patient with antibiotics has been made, one must attempt to identify the site of infection based on clinical signs and symptoms, laboratory or diagnostic radiology studies. Identification of site requires, examination of patient, inspection of all wounds, chest radiograph, and calculation of clinical pulmonary infection score if ventilated, obtaining blood cultures, urinalysis, and line change if clinical suspicion of central venous catheter (CVC) source. If it is impossible to identify site, obtain cultures from all accessible suspected sites and initiate empiric, broad spectrum antibiotics. If likely site can be identified answer these questions: Is intra-abdominal site suspected? Is pulmonary source of infection suspected? Is skin, skin structure or soft tissue site suspected? If yes, does the patient have clinical signs suspicion for necrotizing soft tissue infection (NSTI)? Is a CVC infection suspected? Risk factors for more complicated infections are discussed and specific antibiotic recommendations are provided for each type and severity of clinical infection. Decision to continue, discontinue and/or alter antibiotic/antimicrobial treatment should be based on the clinical response to treatment, diagnostic or interventional findings, and culture and sensitivity data, bearing in mind that not all patients with infections will have positive cultures because of limitations of specimen handling, microbiology laboratory variations, time between specimen acquisition and culture, or presence of effective antibiotics at the time that specimens were obtained. It should also be noted that not all patients with increased temperature/WBC have an infection. Discontinuation of antibiotics is appropriate if cultures and other diagnostic studies are negative.
机译:在做出治疗重症患者抗生素的临床决定后,必须尝试根据临床体征和症状,实验室或放射诊断学研究来确定感染部位。识别部位需要,检查患者,检查所有伤口,检查胸部X射线,并在通风的情况下计算临床肺部感染评分,如果临床怀疑中央静脉导管(CVC)来源,则应进行血液培养,尿液分析和换线。如果无法鉴定出部位,则从所有可及的可疑部位获得培养物,并开始使用经验丰富的广谱抗生素。如果可以识别出可能的部位,请回答以下问题:是否怀疑腹腔内部位?是否怀疑肺部感染源?是否怀疑皮肤,皮肤结构或软组织部位?如果是,患者是否怀疑坏死性软组织感染(NSTI)?是否怀疑有CVC感染?讨论了更复杂感染的危险因素,并针对每种类型和临床感染的严重程度提供了具体的抗生素建议。继续,终止和/或改变抗生素/抗微生物治疗的决定应基于对治疗的临床反应,诊断或干预结果以及培养和敏感性数据,但要记住,并非所有感染患者都会因为局限性而培养阳性标本处理,微生物实验室变化,标本采集与培养之间的时间或标本获取时是否存在有效抗生素的信息。还应注意,并非所有体温升高/ WBC升高的患者都感染。如果培养和其他诊断研究为阴性,则应停用抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号